» Articles » PMID: 39129166

MiRNA Dysregulation in Brain Injury: An Study to Clarify the Role of a MiRNA Set

Abstract

Background: The identification of specific circulating miRNAs has been proposed as a valuable tool for elucidating the pathophysiology of brain damage or injury and predicting patient outcomes.

Objective: This study aims to apply several bioinformatic tools in order to clarify miRNA interactions with potential genes involved in brain injury, emphasizing the need of using a computational approach to determine the most likely correlations between miRNAs and target genes. Specifically, this study centers on elucidating the roles of miR-34b, miR-34c, miR-135a, miR-200c, and miR-451a.

Methods: After a careful evaluation of different software available (analyzing the strengths and limitations), we applied three tools, one to perform an analysis of the validated targets (miRTarBase), and two to evaluate functional annotations (miRBase and TAM 2.0).

Results: Research findings indicate elevated levels of miR-135a and miR-34b in patients with traumatic brain injury (TBI) within the first day post-injury, while miR-200c and miR-34c were found to be upregulated after 7 days. Moreover, miR-451a and miR-135a were found overexpressed in the serum, while miRNAs 34b, 34c, and 200c, had lower serum levels at baseline post brain injury.

Conclusion: This study emphasizes the use of computational methods in determining the most likely relationships between miRNAs and target genes by investigating several bioinformatic techniques to elucidate miRNA interactions with potential genes. Specifically, this study focuses on the functions of miR-34b, miR-34c, miR-135a, miR-200c, and miR-451a, providing an up-to-date overview and suggesting future research directions for identifying theranomiRNAs related to brain injury, both at the tissue and serum levels.

Citing Articles

Traumatic Brain Injury as a Public Health Issue: Epidemiology, Prognostic Factors and Useful Data from Forensic Practice.

Karaboue M, Ministeri F, Sessa F, Nannola C, Chisari M, Cocimano G Healthcare (Basel). 2024; 12(22).

PMID: 39595464 PMC: 11593823. DOI: 10.3390/healthcare12222266.

References
1.
Ahluwalia M, Gaur P, Vaibhav K . Brain Injury and Neurodegeneration: Molecular, Functional, and Translational Approach. Biomedicines. 2023; 11(7). PMC: 10377691. DOI: 10.3390/biomedicines11071947. View

2.
Brett B, Gardner R, Godbout J, Dams-OConnor K, Keene C . Traumatic Brain Injury and Risk of Neurodegenerative Disorder. Biol Psychiatry. 2021; 91(5):498-507. PMC: 8636548. DOI: 10.1016/j.biopsych.2021.05.025. View

3.
Sessa F, Maglietta F, Bertozzi G, Salerno M, Di Mizio G, Messina G . Human Brain Injury and miRNAs: An Experimental Study. Int J Mol Sci. 2019; 20(7). PMC: 6479766. DOI: 10.3390/ijms20071546. View

4.
Carvalho L, Lemes Dos Santos Sanna P, Cristina Dos Santos Afonso C, Bondan E, da Silva Feltran G, Ferreira M . MicroRNA biogenesis machinery activation and lncRNA and REST overexpression as neuroprotective responses to fight inflammation in the hippocampus. J Neuroimmunol. 2023; 382:578149. DOI: 10.1016/j.jneuroim.2023.578149. View

5.
Bonin S, DErrico S, Medeot C, Moreschi C, Sorcaburu Ciglieri S, Peruch M . Evaluation of a Set of miRNAs in 26 Cases of Fatal Traumatic Brain Injuries. Int J Mol Sci. 2023; 24(13). PMC: 10341445. DOI: 10.3390/ijms241310836. View